Table 2.

The fractional metastatic signal in the subset of patients with metastatic disease for whom interpretable T₂-weighted MRI data were available (n=10)

Patient	FU Half-life (min)	FMS	Mets
A	8.9	0.05	+
B	11.9	0.05	+
C	15.5	0.49	+
E	9.4	0.52	+
F	7.5	0.19	+
G	7.4	0.10	+
I	5.9	0.21	+
J	11.8	0.05	+
M	9.3	0.27	+
P	4.9	0.19	+

The FMS is the fraction of detected ¹⁹F signal which would result from metastases if 5FU and its metabolites were distributed uniformly throughout the liver and metastases